(Press-News.org) TAMPA, Fla. - Moffitt Cancer Center, a national leader in cancer care and research and the only National Cancer Institute-designated Comprehensive Cancer Center based in Florida, is presenting new data from dozens of clinical research studies at this year's American Society of Clinical Oncology (ASCO) Annual Meeting, the world's largest clinical cancer research meeting. Moffitt investigators will lead 25 abstract presentations, five education sessions, two cancer-based panels and two clinical science symposia. The virtual meeting is June 4-8.
Highlights include:
Oral Presentations:
Dr. Bijal Shah will present phase 2 results from the ZUMA-3 trial evaluating CAR T-cell therapy for adults with acute lymphoblastic leukemia, a challenging malignancy to treat in this patient population.
- Abstract 7002 - Phase 2 results of the ZUMA-3 study evaluating KTE-X19, an anti-CD19 chimeric antigen receptor (CAR) T-cell therapy, in adult patients (pts) with relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL).
Dr. Taiga Nishihori will present phase 2 results evaluating the efficacy of ixazomib maintenance therapy after allogeneic hematopoietic cell transplantation using reduced intensity fludarabine/melphalan/bortezomib-based conditioning regimen to treat patients with high risk multiple myeloma.
- Abstract 7003 - The results of multicenter phase II, double-blind placebo-controlled trial of maintenance ixazomib after allogeneic hematopoietic cell transplantation (alloHCT) for high-risk multiple myeloma (MM) from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 1302).
Dr. Kosj Yamoah will present results of a prospective study evaluating a genomic classifier in a subset of African American men with prostate cancer. The classifier provides information on underlying biology and independently predicts individual patients' risk of metastasis.
- Abstract 5005 - A prospective validation of the genomic classifier to define high-metastasis risk in a subset of African American men with early localized prostate cancer: VanDAAM study.
Dr. Jonathan Zager will present results of a phase 3 trial evaluating the use of percutaneous hepatic perfusion for ocular melanoma patients with liver metastasis. To date, there is no standard of care for this patient population.
- Abstract 9510 - Percutaneous hepatic perfusion (PHP) with melphalan for patients with ocular melanoma liver metastases: Preliminary results of FOCUS (PHP-OCM-301/301A) phase III trial.
Posters:
Dr. Bijal Shah will present initial results of a novel allogeneic CAR T product that incorporates gene editing technology to delete any donor genes that may cause a patient's immune system to attack the donor CAR T cells.
- Abstract 7516 - Preliminary safety and efficacy of PBCAR0191, an allogeneic, off-the-shelf CD19-targeting CAR-T product, in relapsed/refractory (r/r) CD19+ NHL.
Dr. Hatem Soliman will present phase 2 results evaluating the use of a modified form of the herpes simplex 1 virus that is injected directly into triple-negative breast cancer tumors while patients are undergoing chemotherapy.
- Abstract 578 - A phase 2 trial of talimogene laherparepvec (TVEC) in combination with neoadjuvant chemotherapy for the treatment of nonmetastatic triple-negative breast cancer.
Dr. Frederick Locke will present data from the ALPHA2 study evaluating ALLO-501, an allogeneic CAR T therapy product, in combination with ALLO-647, a monoclonal antibody that depletes lymphocytes in the body to help prepare the patient for the new immune cells, in patients with large B-cell lymphoma.
- Abstract 2529 - First-in-human data of ALLO-501A, an allogeneic chimeric antigen receptor (CAR) T-cell therapy and ALLO-647 in relapsed/refractory large B-cell lymphoma (R/R LBCL): ALPHA2 study.
INFORMATION:
Brief videos with each presenter and a complete list of Moffitt's ASCO presentations are available at http://www.moffitt.org/ASCO.
Experts are available to discuss their research. Please direct media inquiries to Kim Polacek, 813-745-7408, Kim.Polacek@moffitt.org.
About Moffitt Cancer Center
Moffitt is dedicated to one lifesaving mission: to contribute to the prevention and cure of cancer. The Tampa-based facility is one of only 51 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt's scientific excellence, multidisciplinary research, and robust training and education. Moffitt is the No. 11 cancer hospital and has been nationally ranked by U.S. News & World Report since 1999. Moffitt's expert nursing staff is recognized by the American Nurses Credentialing Center with Magnet® status, its highest distinction. With more than 7,000 team members, Moffitt has an economic impact in the state of $2.4 billion. For more information, call 1-888-MOFFITT (1-888-663-3488), visit MOFFITT.org, and follow the momentum on Facebook, Twitter, Instagram and YouTube.
Physicists at the University of Bath in the UK, in collaboration with researchers from the USA, have uncovered a new mechanism for enabling magnetism and superconductivity to co-exist in the same material. Until now, scientists could only guess how this unusual coexistence might be possible. The discovery could lead to applications in green energy technologies and in the development of superconducting devices, such as next-generation computer hardware.
As a rule, superconductivity (the ability of a material to pass an electrical current with perfect efficiency) and magnetism (seen at work in fridge magnets) make poor bedfellows because the alignment of the tiny electronic magnetic particles in ferromagnets ...
A catastrophic drop in atmospheric ozone levels around the tropics is likely to have contributed to a bottleneck in the human population around 60 to 100,000 years ago, an international research team has suggested. The ozone loss, triggered by the eruption of the Toba supervolcano located in present-day Indonesia, might solve an evolutionary puzzle that scientists have been debating for decades.
"Toba has long been posited as a cause of the bottleneck, but initial investigations into the climate variables of temperature and precipitation provided no concrete ...
In interstellar dust clouds, turbulence must first dissipate before a star can form through gravity. A German-French research team has now discovered that the kinetic energy of the turbulence comes to rest in a space that is very small on cosmic scales, ranging from one to several light-years in extent. The group also arrived at new results in the mathematical method: Previously, the turbulent structure of the interstellar medium was described as self-similar - or fractal. The researchers found that it is not enough to describe the structure mathematically as a single fractal, a self-similar structure as known from the Mandelbrot set. Instead, they added several different fractals, so-called multifractals. The new methods can thus be used to resolve ...
Researchers from North Carolina State University have developed a new state-of-the-art method for controlling how artificial intelligence (AI) systems create images. The work has applications for fields from autonomous robotics to AI training.
At issue is a type of AI task called conditional image generation, in which AI systems create images that meet a specific set of conditions. For example, a system could be trained to create original images of cats or dogs, depending on which animal the user requested. More recent techniques have built on this to incorporate conditions regarding an image layout. This allows users to specify which types of objects they want to appear in particular places on the screen. ...
Amsterdam, June 1, 2021 - The Treatabolome project is a research initiative to develop a freely available, interoperable online platform dedicated to disseminating rare disease and gene-specific treatment information to healthcare professionals regardless of their level of specialized expertise. Developed under the Solve-RD European Research Project, it is intended to reduce treatment delays for patients with rare diseases by directly linking diagnosis and treatment information. This initiative is highly relevant to neuromuscular disorders as they are rare diseases by definition. In this special issue of the Journal of Neuromuscular Diseases, experts contribute Treatabolome-feeding systematic literature reviews on rare neurological ...
Neutrons - Space ice, un-Earthly cold
Researchers from NASA's Jet Propulsion Laboratory and Oak Ridge National Laboratory successfully created amorphous ice, similar to ice in interstellar space and on icy worlds in our solar system. They documented that its disordered atomic behavior is unlike any ice on Earth.
The findings could help interpret data from future NASA missions such as Europa Clipper, which will assess the habitability of Jupiter's moon, Europa.
Using the Spallation Neutron Source's SNAP instrument, the scientists replicated the cold vacuum of space and added a few molecules ...
Single atomic defect is the smallest structural unit of solid material. The construction of devices based on single defect can reach the limit of miniaturization of semiconductor devices. In the past decades, the creation and manipulation of single defects in semiconductors opened a new research field, and could be used to physically realize "qubits" of solid-state quantum computation through spin or electron charge. Most interest have focused on the studies of spin quantum computing. However, the spin manipulation need an optical and magnetic field. On the contrary, multiple ...
Leipzig. The smoke from the extreme forest fires on the US West Coast in September 2020 travelled over many thousands of kilometres to Central Europe, where it continued to affect the atmosphere for days afterwards. A comparison of ground and satellite measurements now shows: The forest fire aerosol disturbed the free troposphere over Leipzig in Germany as never before. An evaluation by an international research team led by the Leibniz Institute for Tropospheric Research (TROPOS) revealed an extraordinary optical thickness on 11 September 2020, which attenuated ...
Oncotarget published "Development of a ghrelin receptor inverse agonist for positron emission tomograph" which reported that imaging of Ghrelin receptors in vivo provides unique potential to gain deeper understanding on Ghrelin and its receptors in health and disease, in particular, in cancer.
Ghrelin, an octanoylated 28-mer peptide hormone, activates the constitutively active growth hormone secretagogue receptor type 1a with nanomolar activity.
The authors developed novel compounds, derived from the potent inverse agonist K- -FwLL-NH2 but structurally varied by lysine conjugation ...
Oncotarget published "Global DNA hypermethylation pattern and unique gene expression signature in liver cancer from patients with Indigenous American ancestry" which reported that contrasting with this pattern, the age structure of HCC in Andean people displays a bimodal distribution with half of the patients developing HCC in adolescence and early adulthood.
To deepen the understanding of the molecular determinants of the disease in this population, the authors conducted an integrative analysis of gene expression and DNA methylation in HCC developed by 74 Peruvian patients, including 39 adolescents and young adults.
While genome-wide hypomethylation ...
